EHTH

eHealth, Inc. Q1 2008 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for eHealth, Inc., covering the three-month period ended March 31, 2008. eHealth operates an Internet-based insurance agency platform enabling individuals, families, and small businesses to research, compare, and purchase health insurance products. The company is licensed to sell health insurance in all 50 states and the District of Columbia. As of March 31, 2008, the company reported an estimated membership of approximately 558,200.

Key Financial Metrics

Revenue Composition: Commission revenue accounted for 92% of total revenue ($24.1 million), while sponsorship, licensing, and other revenue accounted for 8% ($2.2 million).
Profitability: Operating income was $4.7 million (18% of revenue). The effective tax rate was 44%, though management expects cash tax payments to be near the alternative minimum tax rate (~3%) due to net operating loss carryforwards.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 35% year-over-year, driven primarily by a 31% increase in commission revenue due to membership growth (up 26% to 558,200 members) and higher commission overrides.
• Expense Increases: Marketing and advertising expenses rose 39% to $9.6 million, increasing as a percentage of revenue from 36% to 37%. This was driven by higher online advertising costs and marketing partner fees.
• Stock-Based Compensation: Total stock-based compensation expense more than doubled to $0.7 million from $0.3 million in the prior year quarter.
• Customer Care & Technology: While absolute costs for customer care (up 21%) and technology (up 16%) increased, both declined as a percentage of total revenue due to economies of scale.
• Liquidity: Cash and cash equivalents increased by $9.5 million, supported by strong operating cash flows and proceeds from stock option exercises.

Guidance, Outlook, and Risks

Management Outlook:

• Management expects total revenue to continue growing in absolute dollars.
• Marketing and advertising expenses are expected to increase in absolute dollars and as a percentage of revenue for the remainder of 2008 due to rising acquisition costs and stock-based compensation.
• Customer care, technology, and general administrative expenses are expected to increase in absolute dollars but decline as a percentage of revenue.
• Interest income is expected to decrease due to declining yields on invested cash and securities.

• Carrier Concentration: The top three carriers (UnitedHealthcare, Wellpoint, Aetna) represented 45% of total revenue. Relationships are non-exclusive and terminable on short notice.
• Regulatory Environment: The business is heavily regulated in all 50 states. Changes in "guaranteed issue" laws or universal healthcare proposals could reduce demand for private insurance.
• Acquisition Costs: Rising costs for online advertising and competition from carriers for search engine placement are increasing the cost to acquire new members.
• China Operations: The company is expanding operations in China, facing risks related to unfamiliar laws, intellectual property protection, and regulatory uncertainty.
• System Reliance: Revenue recognition depends on timely and accurate reporting from insurance carriers; delays or errors in carrier reporting could impact financial results.

Investor Verification Checklist

• Membership Accuracy: Verify the methodology for estimating active membership, as the company relies on carrier payment data rather than direct cancellation notices.
• Carrier Concentration: Monitor the stability of relationships with UnitedHealthcare, Wellpoint, and Aetna, which collectively drive nearly half of revenue.
• Acquisition Cost Trends: Track the "Acquisition cost per individual on IFP submitted applications," which rose to $55.41 in Q1 2008 from $49.18 in Q1 2007.
• Cash Tax Liability: Confirm the realization of net operating loss carryforwards to validate the expectation of low cash tax payments despite a high effective tax rate.
• China Expansion: Assess the progress and regulatory compliance of the pilot programs in Xiamen and Shanghai.